top of page

FDA-Cleared AI-Enabled Physician Prescribed

Screenshot_2023-10-10_at_8.57_edited.png

Parkinson's Management on Apple Watch

Get NeuroRPM-Rx 

About
NeuroRPM-Rx
for Clinical Care

Rx notebook_white _transparent_edited.pn

Empower Parkinson’s care with NeuroRPM-Rx. NeuroRPM-Rx uses Apple Watch, mobile software, and advanced analytics to monitor key Parkinson’s motor symptoms, including bradykinesia, tremor, and dyskinesia, while supporting medication tracking and supplemental health data integration.

  • Objective Symptom Monitoring: Detect and visualize Parkinson’s motor symptoms from Apple Watch data to support a clearer view of symptom patterns over time.

  • Medication Tracking and Insights: Help patients and care teams review medication timing and symptom patterns in the context of daily routines.

  • Clinical Care Support: Provide physicians and care teams with objective data that can help inform treatment discussions, medication adjustments, and ongoing disease management.
     

If you are interested in using NeuroRPM-Rx for Parkinson’s remote monitoring, please visit our
sign-up page to learn more and get started.

About
NeuroRPM-CT
for Clinical Trials

Support Parkinson’s clinical trials and therapy development with NeuroRPM-CT. Designed for pharmaceutical, medical device, and research partners, NeuroRPM-CT provides objective symptom monitoring, medication context, and real-world data to complement traditional clinical trial assessments.
 

  • Objective Symptom Monitoring: Track Parkinson’s motor symptoms including bradykinesia, tremor, and dyskinesia during clinical research.

  • Baseline and Longitudinal Tracking: Evaluate symptom patterns before, during, and after a clinical intervention.

  • Treatment Response Insights: Support exploratory digital endpoints, therapy development, and review of symptom changes over time.
     

If you are interested in using NeuroRPM-CT for a clinical trial or therapy development program, contact us to discuss how we may support your study.

Contact Us

contact
bottom of page